Replies to post #4993 on GTC Biotherapeutics (fka GTCB)

[Isotope Feeney]

If its any consolation, I own 5 other micro cap biotech's
and the volume was low on all of them, in fact GTCB did
a little better than the others.

[silly beaver]

A pattern is a pattern until it is broken. What if GTCB went to $3/share and never came back down to a buck again? You would be left kicking yourself for missing the real move up and wonder why you were flipping for nickels and dimes in the first place. If that is your objective to flip for pennies more power to you, but the vast majority of folks on this message board who have done extensive due diligence are in GTCB for much more than a few pennies.

[DewDiligence]

>Dew - Any thoughts on today's "volume" (if you want to call it that!)<

Until you mentioned it, I hadn’t noticed that the volume was low.

>Do you anticipate any news that might affect the share price from the upcoming corporate presentation?<

Unlikely but possible, IMO. In the time I’ve been following GTC, they’ve issued a material disclosure at an investor conference only once: when it was announced in May 2005 that the EMEA had made plans to inspect GTC’s production facilities.